List of works by Myron J Levin

2013 IDSA clinical practice guideline for vaccination of the immunocompromised host

scientific article

2477. Impact of Varicella Vaccination in the United States (US): A Dynamic Model-Based Analysis

2479. Varicella Zoster Immune Globulin Is Effective up to 10 Days Following Varicella Exposure in Pregnant Women, Immunocompromised Patients, and Infants: Results From a Large, Open-Label Expanded-Access Program

2488. The Impact of Reactogenicity After Administration of the Recombinant Zoster Vaccine Upon the Physical Functioning and Quality of Life of Older Adults

2778. Impact of Reactogenicity on Quality of Life and Physical Functioning in Adults ≥50 Years Receiving Both Doses of the Adjuvanted Recombinant Zoster Vaccine

2780. Reactogenicity Profile of Adjuvanted Recombinant Zoster Vaccine after Dose 2 According to the Intensity of the Same Event Experienced after Dose 1

scientific article published on 23 October 2019

A Prospective Study of the Herpes Zoster Severity of Illness ⬇️

scientific article published on 01 October 2010

A double-blind, randomized, controlled, multi-center safety and immunogenicity study of a refrigerator-stable formulation of VARIVAX®

scientific article published on 23 August 2018

A phase I-II study of live attenuated varicella-zoster virus vaccine to boost immunity in human immunodeficiency virus-infected children with previous varicella

scientific article

A real-time PCR assay to identify and discriminate among wild-type and vaccine strains of varicella-zoster virus and herpes simplex virus in clinical specimens, and comparison with the clinical diagnoses

scientific article

A vaccine to prevent herpes zoster and postherpetic neuralgia in older adults

scientific article

Adjuvanted Recombinant Glycoprotein E Herpes Zoster Vaccine

scientific article published on 01 March 2020

Administration of live varicella vaccine to HIV-infected children with current or past significant depression of CD4(+) T cells

scientific article published on 14 June 2006

Advances in the understanding of the pathogenesis and epidemiology of herpes zoster

scientific article

Anti-influenza serum and mucosal antibody responses after administration of live attenuated or inactivated influenza vaccines to HIV-infected children

scientific article published on October 2010

Antibody and B cell responses to an investigational adjuvanted RSV vaccine for older adults

scientific article published on 03 June 2019

Antibody persistence and immunologic memory after sequential pneumococcal conjugate and polysaccharide vaccination in HIV-infected children on highly active antiretroviral therapy

scientific article published on 14 August 2013

Association between prodromal pain and the severity of acute herpes zoster and utilization of health care resources

scientific article published on 19 May 2011

B and T Cell Phenotypic Profiles of African HIV-Infected and HIV-Exposed Uninfected Infants: Associations with Antibody Responses to the Pentavalent Rotavirus Vaccine

scientific article published in January 2017

Broadly reactive human CD8 T cells that recognize an epitope conserved between VZV, HSV and EBV.

scientific article

Cellular and Humoral Responses to a Second Dose of Herpes Zoster Vaccine Administered 10 Years After the First Dose Among Older Adults

scientific article

Changing Trends in Complications and Mortality Rates Among US Youth and Young Adults With HIV Infection in the Era of Combination Antiretroviral Therapy

scientific article

Clinical and in vitro evaluation of cidofovir for treatment of adenovirus infection in pediatric hematopoietic stem cell transplant recipients.

scientific article

Comparative Immune Responses to Licensed Herpes Zoster Vaccines

article

Comparative humoral and cellular immunogenicity and safety of human papillomavirus (HPV)-16/18 AS04-adjuvanted vaccine and HPV-6/11/16/18 vaccine in healthy women aged 18-45 years: follow-up through Month 48 in a Phase III randomized study

scientific article published in January 2014

Comparative immunogenicity and safety of human papillomavirus (HPV)-16/18 vaccine and HPV-6/11/16/18 vaccine: follow-up from months 12-24 in a Phase III randomized study of healthy women aged 18-45 years

scientific article published in December 2011

Comparison of the immunogenicity and safety of Cervarix and Gardasil human papillomavirus (HPV) cervical cancer vaccines in healthy women aged 18-45 years

scientific article

Comparison of the immunogenicity of the human papillomavirus (HPV)-16/18 vaccine and the HPV-6/11/16/18 vaccine for oncogenic non-vaccine types HPV-31 and HPV-45 in healthy women aged 18-45 years

scientific article published in December 2011

Complications of herpes zoster in immunocompetent older adults: Incidence in vaccine and placebo groups in two large phase 3 trials

scientific article published on 17 February 2018

Correlation between levels of human papillomavirus (HPV)-16 and 18 antibodies in serum and cervicovaginal secretions in girls and women vaccinated with the HPV-16/18 AS04-adjuvanted vaccine

scientific article published on 01 December 2010

Cost-effectiveness of herpes zoster vaccine: flawed assumptions regarding efficacy against postherpetic neuralgia.

scientific article

Cytokines Produced in Response to Varicella-Zoster Virus (VZV) Infection of ARPE-19 Cells Stimulate Lymphocyte Chemotaxis

scientific article published on 18 August 2017

Cytomegalovirus-specific cell-mediated immunity in HIV-infected children on HAART

scientific article published on 01 March 2006

DNA sequence variability in isolates recovered from patients with postvaccination rash or herpes zoster caused by Oka varicella vaccine

scientific article published on 10 January 2007

Decline in Varicella‐Zoster Virus (VZV)–Specific Cell‐Mediated Immunity with Increasing Age and Boosting with a High‐Dose VZV Vaccine ⬇️

scientific article published on October 17, 2003

Determinants of vaccine immunogenicity in HIV-infected pregnant women: analysis of B and T cell responses to pandemic H1N1 monovalent vaccine

scientific article

Development of Resistance to Acyclovir during Chronic Infection with the Oka Vaccine Strain of Varicella‐Zoster Virus, in an Immunosuppressed Child ⬇️

scientific article published on September 26, 2003

Development of a measure of the burden of pain due to herpes zoster and postherpetic neuralgia for prevention trials: Adaptation of the brief pain inventory

article

Effect of a zoster vaccine on herpes zoster-related interference with functional status and health-related quality-of-life measures in older adults

scientific article

Effects of varying antigens and adjuvant systems on the immunogenicity and safety of investigational tetravalent human oncogenic papillomavirus vaccines: results from two randomized trials

scientific article published on 25 March 2014

Efficacy and serious adverse events profile of the adjuvanted recombinant zoster vaccine in adults with pre-existing potential immune-mediated diseases: a pooled post hoc analysis on two parallel randomized trials

scientific article published on 10 September 2020

Efficacy of an adjuvanted herpes zoster subunit vaccine in older adults

scientific article published on 28 April 2015

Efficacy of the Herpes Zoster Subunit Vaccine in Adults 70 Years of Age or Older

scientific article

Efficacy results of a trial of a herpes simplex vaccine

scientific article published on January 2012

Efficacy, safety, and immunogenicity of the human papillomavirus 16/18 AS04-adjuvanted vaccine in women older than 25 years: 4-year interim follow-up of the phase 3, double-blind, randomised controlled VIVIANE study

scientific article published on September 2014

Efficacy, safety, and tolerability of herpes zoster vaccine in persons aged 50-59 years

scientific article

Employment related productivity loss associated with herpes zoster and postherpetic neuralgia: a 6-month prospective study

scientific article published on 28 January 2012

Epidemiology, clinical presentation, and antibody response to primary infection with herpes simplex virus type 1 and type 2 in young women

scientific article published on 19 October 2012

Evaluation of the cost-effectiveness in the United States of a vaccine to prevent herpes zoster and postherpetic neuralgia in older adults

scientific article (publication date: November 2007)

Evaluation of two frailty indices, with practical application in a vaccine clinical trial

scientific article published on 21 June 2019

Factors that affect in vitro measurement of the susceptibility of herpes simplex virus to nucleoside analogues

scientific article published on 13 December 2006

Four-year persistence of type-specific immunity after quadrivalent human papillomavirus vaccination in HIV-infected children: Effect of a fourth dose of vaccine

scientific article published on 23 February 2017

Fractionation of neurons and satellite cells from human sensory ganglia in order to study herpesvirus latency

scientific article published on 01 June 2002

GB virus C infection in children with perinatal human immunodeficiency virus infection

scientific article published in May 2005

HSV-1 and HSV-2 seroprevalence in the united states among asymptomatic women unaware of any herpes simplex virus infection (Herpevac Trial for Women).

scientific article published on February 2014

Hepatitis C prevalence in children with perinatal human immunodeficiency virus infection enrolled in a long-term follow-up protocol

scientific article published in October 2004

Herpes Simplex Virus and Varicella-Zoster Virus

scientific article published on June 2016

Herpes Zoster Vaccines

scientific article published on 01 September 2018

Herpes Zoster and Herpes Zoster Vaccine Rates Among Adults Living With and Without HIV in the Veterans Aging Cohort Study

scientific article published on 01 December 2018

Herpes Zoster and Its Prevention by Vaccination

scientific article published on 09 April 2020

Herpes simplex virus resistance to acyclovir and penciclovir after two decades of antiviral therapy

scientific article

Herpes zoster with skin lesions and meningitis caused by 2 different genotypes of the Oka varicella-zoster virus vaccine

scientific article published in November 2008

Heterogeneity of T Cell Responses to Pandemic pH1N1 Monovalent Vaccine in HIV-Infected Pregnant Women

scientific article

Human sensory neurons derived from induced pluripotent stem cells support varicella-zoster virus infection

scientific article

Humoral, mucosal, and cell-mediated immunity against vaccine and nonvaccine genotypes after administration of quadrivalent human papillomavirus vaccine to HIV-infected children

scientific article

Immune Responses to a Recombinant Glycoprotein E Herpes Zoster Vaccine in Adults Aged ≥50 Years.

scientific article published on 26 February 2018

Immune Senescence Factors Associated with the Immunogenicity of a Live Attenuated Zoster Vaccine (ZV) in Older Adults.

scientific article published on 4 October 2017

Immune correlates of herpes zoster in HIV-infected children and youth

scientific article published on 14 December 2011

Immune response and reactogenicity of intradermal administration versus subcutaneous administration of varicella-zoster virus vaccine: an exploratory, randomised, partly blinded trial

scientific article published on 6 April 2016

Immune response to a refrigerator-stable zoster vaccine

scientific article published on September 2009

Immune responses to zoster vaccines

scientific article published on 24 January 2019

Immunization of HIV-infected children with varicella vaccine

scientific article published on 01 August 2001

Immunogenicity and immunologic memory after hepatitis B virus booster vaccination in HIV-infected children receiving highly active antiretroviral therapy

scientific article

Immunogenicity and safety of zoster vaccine live administered with quadrivalent influenza virus vaccine

scientific article

Immunogenicity, immunologic memory, and safety following measles revaccination in HIV-infected children receiving highly active antiretroviral therapy

scientific article

Impact of Reactogenicity After Two Doses of Recombinant Zoster Vaccine Upon Physical Functioning and Quality of Life: An Open Phase III Trial in Older Adults

scientific article published on 12 June 2020

Impairments in health functioning and sleep quality in older adults with a history of depression

scientific article

Incidence of herpes zoster and persistent post-zoster pain in adults with or without diabetes in the United States

scientific article

Inflammation and Immune Activation in Antiretroviral-Treated Human Immunodeficiency Virus Type 1-Infected African Infants and Rotavirus Vaccine Responses

scientific article published on March 2017

Influence of age and nature of primary infection on varicella-zoster virus-specific cell-mediated immune responses

scientific article

Intestinal Integrity Biomarkers in Early Antiretroviral-Treated Perinatally HIV-1-Infected Infants.

scientific article published on 12 May 2018

Kinetics and determining factors of the virologic response to antiretrovirals during pregnancy

scientific article

Kinetics of viral shedding and immune responses in adults following administration of cold-adapted influenza vaccine

scientific article published on October 2009

Long-term persistence of zoster vaccine efficacy

scientific article

Low Rates of Vaccination for Herpes Zoster in Older People Living with HIV.

scientific article

Major depressive disorder and immunity to varicella-zoster virus in the elderly

scientific article

Maternal Lopinavir/Ritonavir Is Associated with Fewer Adverse Events in Infants than Nelfinavir or Atazanavir

scientific article

Measurement of cell-mediated immunity with a Varicella-Zoster Virus-specific interferon-gamma ELISPOT assay: responses in an elderly population receiving a booster immunization

scientific article published in January 2003

Medical conditions at enrollment do not impact efficacy and safety of the adjuvanted recombinant zoster vaccine: a pooled post-hoc analysis of two parallel randomized trials

scientific article published on 28 June 2019

Metabolic Phenotypes of Response to Vaccination in Humans

scientific article published on 9 May 2017

Nectin-1/HveC Mediates herpes simplex virus type 1 entry into primary human sensory neurons and fibroblasts

scientific article

Paradigm shifting vaccines: prophylactic vaccines against latent varicella-zoster virus infection and against HPV-associated cancer

scientific article

Persistence of memory B-cell and T-cell responses to the quadrivalent HPV vaccine in HIV-infected children

scientific article published on 8 February 2018

Persistence of varicella-zoster virus cell-mediated immunity after the administration of a second dose of live herpes zoster vaccine

scientific article published on 01 January 2019

Persistent sleep disturbance: a risk factor for recurrent depression in community-dwelling older adults

scientific article

Pharmacokinetics and safety of intravenous cidofovir for life-threatening viral infections in pediatric hematopoietic stem cell transplant recipients

scientific article published on 2 March 2015

Phase I/II trial of intravenous recombinant interleukin-2 in HIV-infected children

scientific article published on October 2003

Phenotypic and functional characterization of ex vivo T cell responses to the live attenuated herpes zoster vaccine.

scientific article published on 15 August 2007

Post hoc analysis of reactogenicity trends between dose 1 and dose 2 of the adjuvanted recombinant zoster vaccine in two parallel randomized trials

scientific article published on 29 April 2020

Postentry events are responsible for restriction of productive varicella-zoster virus infection in Chinese hamster ovary cells

scientific article published on November 2006

Predictors of postherpetic neuralgia among patients with herpes zoster: a prospective study

scientific article published on 01 November 2010

Prevention of herpes zoster and its painful and debilitating complications

scientific article

Prevention strategies for herpes zoster and post-herpetic neuralgia

scientific article

Prevention strategies: herpes zoster, post-herpetic neuralgia and immunogenicity.

scientific article published on September 2007

Prior depression history and deterioration of physical health in community-dwelling older adults--a prospective cohort study

scientific article

Progression of HPV infection to detectable cervical lesions or clearance in adult women: Analysis of the control arm of the VIVIANE study.

scientific article published on 19 December 2015

Quadrivalent Ann Arbor strain live-attenuated influenza vaccine

scientific article

Quality of Life Impact of an Adjuvanted Recombinant Zoster Vaccine in Adults Aged 50 Years and Older

scientific article published on 01 July 2019

Recombinant Zoster Vaccine Is Efficacious and Safe in Frail Individuals

scientific article published on 16 November 2020

Recommendations for the Management of Herpes Zoster

scientific article (publication date: 2007)

Recurrent herpes zoster in the Shingles Prevention Study: Are second episodes caused by the same varicella-zoster virus strain?

scientific article published on 01 November 2019

Regulatory T Cells in Infections: Getting It Just Right

scientific article published on 25 April 2016

Resistance of herpes simplex virus infections to nucleoside analogues in HIV-infected patients

scientific article published in November 2004

Resistance to antiretrovirals in HIV-infected pregnant women

scientific article published on 28 March 2009

Safety and Varicella Outcomes in In Utero-Exposed Newborns and Preterm Infants Treated With Varicella Zoster Immune Globulin (VARIZIG): A Subgroup Analysis of an Expanded-Access Program

scientific article published on 27 November 2019

Safety and immunogenicity of 2009 pH1N1 vaccination in HIV-infected pregnant women

scientific article

Safety and immunogenicity of a live attenuated pentavalent rotavirus vaccine in HIV-exposed infants with or without HIV infection in Africa

scientific article published on 20 September 2016

Safety and immunogenicity of a live attenuated varicella vaccine in VZV-seropositive HIV-infected adults

scientific article published on 15 April 2010

Safety and immunogenicity of a quadrivalent human papillomavirus (types 6, 11, 16, and 18) vaccine in HIV-infected children 7 to 12 years old.

scientific article

Safety and tolerability of antiretrovirals during pregnancy

scientific article

Safety of herpes zoster vaccine in the shingles prevention study: a randomized trial

scientific article published on 01 May 2010

Safety of zoster vaccine in elderly adults following documented herpes zoster

scientific article published on 30 April 2013

Safety, tolerability, and immunogenicity after 1 and 2 doses of zoster vaccine in healthy adults ≥60 years of age

scientific article published on 07 December 2011

Safety, tolerability, and immunogenicity of zoster vaccine in subjects with a history of herpes zoster

scientific article published on 21 April 2010

Serious adverse events are uncommon with combination neonatal antiretroviral prophylaxis: a retrospective case review

scientific article

Shedding of live vaccine virus, comparative safety, and influenza-specific antibody responses after administration of live attenuated and inactivated trivalent influenza vaccines to HIV-infected children

scientific article published on 10 June 2008

Short-term and long-term effects of highly active antiretroviral therapy on the incidence of herpes zoster in HIV-infected children

scientific article published on February 2009

Sleep disturbance and depression recurrence in community-dwelling older adults: a prospective study

scientific article published on 02 September 2008

Structural Validation of the Hamilton Depression Rating Scale

article

Studies with herpes zoster vaccines in immune compromised patients

scientific article

Susceptibilities of herpes simplex viruses to penciclovir and acyclovir in eight cell lines

scientific article

Susceptibility of Herpes Simplex Virus Isolates to Nucleoside Analogues and the Proportion of Nucleoside‐Resistant Variants after Repeated Topical Application of Penciclovir to Recurrent Herpes Labialis ⬇️

scientific article published on March 26, 2003

T cell responses of HIV-infected children after administration of inactivated or live attenuated influenza vaccines

scientific article

Th1 memory differentiates recombinant from live herpes zoster vaccines

article by Myron J Levin et al published 1 October 2018 in Journal of Clinical Investigation

The Effect of Age on the Immunogenicity of the Live Attenuated Zoster Vaccine Is Predicted by Baseline Regulatory T Cells and Varicella-Zoster Virus-Specific T Cell Immunity

scientific article published on 17 July 2019

The Impact of Reactogenicity After the First Dose of Recombinant Zoster Vaccine on the Physical Functioning and Quality of Life of Older Adults: An Open-Label, Phase III Trial

scientific article published on 01 July 2019

The epidemiology of adolescents living with perinatally acquired HIV: A cross-region global cohort analysis

scientific article published in March 2018

The impact of acute herpes zoster pain and discomfort on functional status and quality of life in older adults

scientific article published in July 2007

The impact of herpes zoster and postherpetic neuralgia on health-related quality of life: a prospective study

scientific article

The prevention and management of herpes zoster

scientific article

The rationale for quadrivalent influenza vaccines

scientific article published on January 2012

The relative efficacy of trivalent live attenuated and inactivated influenza vaccines in children and adults

scientific article

Understanding the immunology of Shingrix, a recombinant glycoprotein E adjuvanted herpes zoster vaccine

scientific article published on 17 April 2019

Vaccination against Herpes Zoster and Postherpetic Neuralgia

scientific article

Vaccination against herpes zoster in developed countries: state of the evidence

scientific article

Validation of a 3-factor scoring model for the Pittsburgh sleep quality index in older adults

scientific article

Varicella vaccine in the United States: a decade of prevention and the way forward

scientific article published on 01 March 2008

Varicella zoster immune globulin (VARIZIG) administration up to 10 days after varicella exposure in pregnant women, immunocompromised participants, and infants: Varicella outcomes and safety results from a large, open-label, expanded-access program

scientific article published on 03 July 2019

Varicella zoster virus-specific immune responses to a herpes zoster vaccine in elderly recipients with major depression and the impact of antidepressant medications

scientific article published on 13 February 2013

Varicella-Zoster Virus DNA in Blood After Administration of Herpes Zoster Vaccine

scientific article published on 2 February 2018

Varicella-Zoster Virus-Specific Cellular Immune Responses to the Live Attenuated Zoster Vaccine in Young and Older Adults.

scientific article

Varicella-Zoster virus-specific cell-mediated immunity in HIV-infected children receiving highly active antiretroviral therapy

scientific article published on 9 June 2004

Varicella-zoster virus DNA in cells isolated from human trigeminal ganglia

scientific article

Varicella-zoster virus activates inflammatory cytokines in human monocytes and macrophages via Toll-like receptor 2.

scientific article

Varicella-zoster virus infections in patients treated with fingolimod: risk assessment and consensus recommendations for management

scientific article

Varicella-zoster virus inhibits autophagosome-lysosome fusion and the degradation stage of mTOR-mediated autophagic flux

scientific article published on 24 July 2018

Varicella-zoster virus-specific antibody responses in 50-59-year-old recipients of zoster vaccine

scientific article

Varicella-zoster virus-specific enzyme-linked immunospot assay responses and zoster-associated pain in herpes zoster subjects

scientific article

Varicella-zoster virus-specific immune responses in elderly recipients of a herpes zoster vaccine

scientific article

Varicella-zoster virus-specific immune responses to herpes zoster in elderly participants in a trial of a clinically effective zoster vaccine

scientific article

Workshop on immunizations in older adults: identifying future research agendas.

scientific article published in April 2010

Paulina is supported by:

About Paulina

Help